Genetic control of quiescence in hematopoietic stem cells

Cell Cycle

Volumn 12, Issue 15, 2013, Pages 2376-2383

  Yamada, Takeshi ^a   Park, Chun Shik ^a   Daniel Lacorazza, H ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

G0S2; Hematopoietic stem cells; Quiescence

Indexed keywords

ANGIOPOIETIN 1; BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; INTEGRIN RECEPTOR; NUCLEOLIN; PROTEIN; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL CYCLE ARREST; CELL DIVISION; CELL INTERACTION; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOSOL; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; GENETIC DAMAGE; GENETIC REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPRECIPITATION; LIPID METABOLISM; LONGEVITY; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SENESCENCE; STEM CELL; STEM CELL NICHE;

G0S2; HEMATOPOIETIC STEM CELLS; QUIESCENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA-BINDING PROTEINS;

EID: 84881504235     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25416     Document Type: Review

References (83)

1. Zhang J, Li L. Stem cell niche: microenvironment and beyond. J Biol Chem 2008; 283:9499-503; PMID:18272517; http://dx.doi.org/10.1074/jbc. R700043200
2. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008; 8:290-301; PMID:18323850; http://dx.doi.org/10.1038/nri2279
3. Kiel MJ, Morrison SJ. Maintaining hematopoietic stem cells in the vascular niche. Immunity 2006; 25:862-4; PMID:17174928; http://dx.doi.org/10. 1016/j.immuni.2006.11.005
4. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006; 116:1195-201; PMID:16670760; http://dx.doi.org/10.1172/JCI28568
5. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836-41; PMID:14574412; http://dx.doi.org/10.1038/nature02041
6. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841-6; PMID:14574413; http://dx.doi.org/10.1038/nature02040
7. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005; 20:349-56; PMID:16174874; http://dx.doi.org/10.1152/physiol.00025.2005
8. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481:457-62; PMID:22281595; http://dx.doi.org/10.1038/nature10783
9. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010; 465:793-7; PMID:20535209; http://dx.doi.org/10.1038/ nature09135
10. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458:904-8; PMID:19212321; http://dx.doi.org/10.1038/nature07815
11. Brenet F, Kermani P, Spektor R, Rafii S, Scandura JM. TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy. J Exp Med 2013; 210:623-39; PMID:23440043; http://dx.doi.org/10.1084/jem.20121610
12. Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci U S A 2006; 103:14134-9; PMID:16968775; http://dx.doi. org/10.1073/pnas. 0604568103
13. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804-8; PMID:10710306; http://dx.doi.org/10.1126/science.287.5459.1804
14. Yuan Y, Shen H, Franklin DS, Scadden DT, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 2004; 6:436-42; PMID:15122268; http://dx.doi.org/10.1038/ncb1126
15. Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y, et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 2011; 9:262-71; PMID:21885021; http://dx.doi.org/10.1016/ j. stem.2011.06.014
16. Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, et al. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 2011; 9:247-61; PMID:21885020; http://dx.doi.org/10.1016/j.stem.2011.07.003
17. Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, Shaw CA, et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004; 2:e301; PMID:15459755; http://dx.doi.org/10.1371/journal. pbio.0020301
18. Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, et al. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 2009; 15:341-52; PMID:19345332; http://dx.doi.org/10.1016/j. ccr.2009.02.016
19. Ficara F, Murphy MJ, Lin M, Cleary ML. Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell 2008; 2:484-96; PMID:18462698; http://dx.doi.org/10.1016/j.stem.2008.03.004
20. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128:325-39; PMID:17254970; http://dx.doi.org/10.1016/j. cell.2007.01.003
21. Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, Yamazaki S, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007; 1:101-12; PMID:18371339; http://dx.doi.org/10.1016/j.stem.2007.02.001
22. Sirin O, Lukov GL, Mao R, Conneely OM, Goodell MA. The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells. Nat Cell Biol 2010; 12:1213-9; PMID:21076412; http://dx.doi.org/10.1038/ncb2125
23. Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, et al. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 2006; 9:175-87; PMID:16530702; http://dx.doi.org/10.1016/j.ccr.2006.02.017
24. Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 4:37-48; PMID:19128791; http://dx.doi.org/10.1016/j.stem.2008.11.006
25. Abbas HA, Maccio DR, Coskun S, Jackson JG, Hazen AL, Sills TM, et al. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell 2010; 7:606-17; PMID:21040902; http://dx.doi.org/10.1016/j.stem.2010.09.013
26. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A 2010; 107:9660-4; PMID:20457898; http://dx.doi.org/10.1073/pnas.1002298107
27. Ichikawa M, Goyama S, Asai T, Kawazu M, Nakagawa M, Takeshita M, et al. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol 2008; 180:4402-8; PMID:18354160
28. Min IM, Pietramaggiori G, Kim FS, Passegué E, Stevenson KE, Wagers AJ. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2008; 2:380-91; PMID:18397757; http://dx.doi.org/10.1016/j.stem.2008.01.015
29. Wang Z, Li G, Tse W, Bunting KD. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 2009; 113:4856-65; PMID:19258595; http://dx.doi.org/10.1182/blood-2008-09-181107
30. Reavie L, Della Gatta G, Crusio K, Aranda-Orgilles B, Buckley SM, Thompson B, et al. Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex. Nat Immunol 2010; 11:207-15; PMID:20081848; http://dx.doi.org/10.1038/ni.1839
31. Reavie L, Buckley SM, Loizou E, Takeishi S, Aranda-Orgilles B, Ndiaye-Lobry D, et al. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell 2013; 23:362-75; PMID:23518350; http://dx.doi.org/10.1016/j.ccr.2013.01.025
32. Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell 2013; 23:347-61; PMID:23518349; http://dx.doi.org/10.1016/j.ccr. 2013.01.026
33. Nakada D, Saunders TL, Morrison SJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 2010; 468:653-8; PMID:21124450; http://dx.doi.org/10.1038/nature09571
34. Gurumurthy S, Xie SZ, Alagesan B, Kim J, Yusuf RZ, Saez B, et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 2010; 468:659-63; PMID:21124451; http://dx.doi.org/10.1038/nature09572
35. Juntilla MM, Patil VD, Calamito M, Joshi RP, Birnbaum MJ, Koretzky GA. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 2010; 115:4030-8; PMID:20354168; http://dx.doi.org/10. 1182/blood-2009-09-241000
36. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205:2397-408; PMID:18809716; http://dx.doi.org/10.1084/jem.20081297
37. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159-65; PMID:22394614
38. Kranc KR, Schepers H, Rodrigues NP, Bamforth S, Villadsen E, Ferry H, et al. Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 2009; 5:659-65; PMID:19951693; http://dx.doi.org/10.1016/j.stem.2009. 11.001
39. Du J, Chen Y, Li Q, Han X, Cheng C, Wang Z, et al. HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Blood 2012; 119:2789-98; PMID:22308296; http://dx.doi.org/10.1182/ blood-2011-10-387902
40. Jeong M, Piao ZH, Kim MS, Lee SH, Yun S, Sun HN, et al. Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol 2009; 183:2495-505; PMID:19625652; http://dx.doi.org/10.4049/jimmunol.0804221
41. Yamada T, Park CS, Burns A, Nakada D, Lacorazza HD. The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells. PLoS One 2012; 7:e38280; PMID:22693613; http://dx.doi.org/10.1371/journal.pone.0038280
42. Russell L, Forsdyke DR. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 1991; 10:581-91; PMID:1930693; http://dx.doi.org/10.1089/dna.1991.10.581
43. Cristillo AD, Heximer SP, Russell L, Forsdyke DR. Cyclosporin A inhibits early mRNA expression of G0/G1 switch gene 2 (G0S2) in cultured human blood mononuclear cells. DNA Cell Biol 1997; 16:1449-58; PMID:9428793; http://dx.doi.org/10.1089/dna.1997.16.1449
44. Zandbergen F, Mandard S, Escher P, Tan NS, Patsouris D, Jatkoe T, et al. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 2005; 392:313-24; PMID:16086669; http://dx.doi.org/10.1042/BJ20050636
45. Teunissen BE, Smeets PJ, Willemsen PH, De Windt LJ, Van der Vusse GJ, Van Bilsen M. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc Res 2007; 75:519-29; PMID:17543901; http://dx.doi.org/10.1016/j.cardiores.2007.04.026
46. Yang X, Lu X, Lombès M, Rha GB, Chi YI, Guerin TM, et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010; 11:194-205; PMID:20197052; http://dx.doi.org/10.1016/j. cmet.2010.02.003
47. Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, et al. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res 2004; 64:5982-7; PMID:15342377; http://dx.doi.org/10.1158/0008-5472.CAN-04-0993
48. Kusakabe M, Watanabe K, Emoto N, Aki N, Kage H, Nagase T, et al. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. Biochem Biophys Res Commun 2009; 390:1283-7; PMID:19878646; http://dx.doi.org/10.1016/j. bbrc.2009.10.137
49. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003; 144:2870-81; PMID:12810542; http://dx.doi.org/10.1210/en. 2003-0043
50. Ma Y, Koza-Taylor PH, DiMattia DA, Hames L, Fu H, Dragnev KH, et al. Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene 2003; 22:4924-32; PMID:12894236; http://dx.doi.org/10.1038/sj. onc.1206728
51. Nakamura N, Shimaoka Y, Tougan T, Onda H, Okuzaki D, Zhao H, et al. Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res 2006; 13:169-83; PMID:17082220; http://dx.doi.org/10.1093/dnares/dsl006
52. Kobayashi S, Ito A, Okuzaki D, Onda H, Yabuta N, Nagamori I, et al. Expression profiling of PBMC-based diagnostic gene markers isolated from vasculitis patients. DNA Res 2008; 15:253-65; PMID:18562305; http://dx.doi.org/10.1093/dnares/dsn014
53. Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005; 15:251-7; PMID:16048752
54. Yoon IK, Kim HK, Kim YK, Song IH, Kim W, Kim S, et al. Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp Gerontol 2004; 39:1369-78; PMID:15489060; http://dx.doi.org/10.1016/j. exger.2004.07.002
55. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007; 41:125-44; PMID:17484127; http://dx.doi.org/10.1007/1-4020-5466-1-7
56. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007; 17:80-6; PMID:17157503; http://dx.doi.org/10.1016/j. tcb.2006.11.010
57. Fähling M, Steege A, Perlewitz A, Nafz B, Mrowka R, Persson PB, et al. Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochim Biophys Acta 2005; 1731:32-40; PMID:16153722; http://dx.doi.org/10.1016/ j.bbaexp.2005.08.005
58. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, Pineda-Roman M, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007; 109:3069-75; PMID:17179226
59. Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, Kim MM, et al. Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs. Nucleic Acids Res 2011; 39:8513-30; PMID:21737422; http://dx.doi.org/10.1093/nar/gkr488
60. Welch C, Santra MK, El-Assaad W, Zhu X, Huber WE, Keys RA, et al. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res 2009; 69:6782-9; PMID:19706769; http://dx.doi.org/10.1158/0008-5472.CAN-09-0128
61. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118:149-61; PMID:15260986; http://dx.doi.org/10.1016/j. cell.2004.07.004
62. Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, Nakamura Y, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007; 1:685-97; PMID:18371409; http://dx.doi.org/10.1016/j.stem.2007.10.020
63. Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM, et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008; 2:274-83; PMID:18371452; http://dx.doi.org/10.1016/j.stem.2008.01.003
64. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 2006; 7:1048-56; PMID:16951689; http://dx.doi.org/10.1038/ni1381
65. Larsson J, Blank U, Helgadottir H, Björnsson JM, Ehinger M, Goumans MJ, et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 2003; 102:3129-35; PMID:12842983; http://dx.doi.org/10. 1182/blood-2003-04-1300
66. Nie Y, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 2008; 205:777-83; PMID:18378795; http://dx.doi.org/10.1084/jem.20072513
67. Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grünewald E, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005; 201:1781-91; PMID:15928197; http://dx.doi.org/10.1084/jem.20041992
68. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106:1232-9; PMID:15845900; http://dx.doi.org/10.1182/blood-2004-11-4422
69. Merchant A, Joseph G, Wang Q, Brennan S, Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010; 115:2391-6; PMID:20107231; http://dx.doi.org/10.1182/blood-2009-09-241703
70. Driessen RL, Johnston HM, Nilsson SK. Membranebound stem cell factor is a key regulator in the initial lodgment of stem cells within the endosteal marrow region. Exp Hematol 2003; 31:1284-91; PMID:14662336; http://dx.doi.org/10.1016/ j. exphem.2003.08.015
71. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, et al. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008; 3:416-28; PMID:18940733; http://dx.doi.org/10.1016/j. stem.2008.07.009
72. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118:477-91; PMID:15315760; http://dx.doi. org/10.1016/j.cell.2004.07. 025
73. Malumbres M, Sotillo R, Santamaría D, Galán J, Cerezo A, Ortega S, et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004; 118:493-504; PMID:15315761; http://dx.doi.org/10.1016/j.cell.2004.08.002
74. Lacombe J, Herblot S, Rojas-Sutterlin S, Haman A, Barakat S, Iscove NN, et al. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 2010; 115:792-803; PMID:19850742; http://dx.doi.org/10.1182/blood-2009-01-201384
75. Abbas HA, Pant V, Lozano G. The ups and downs of p53 regulation in hematopoietic stem cells. Cell Cycle 2011; 10:3257-62; PMID:21957490; http://dx.doi. org/10.4161/cc.10.19.17721
76. Asai T, Liu Y, Di Giandomenico S, Bae N, Ndiaye-Lobry D, Deblasio A, et al. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells. Blood 2012; 120:1601-12; PMID:22776820; http://dx.doi. org/10.1182/blood-2011-11-393983
77. Iriuchishima H, Takubo K, Matsuoka S, Onoyama I, Nakayama KI, Nojima Y, et al. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. Blood 2011; 117:2373-7; PMID:21190997; http://dx.doi.org/10.1182/blood-2010-07-294801
78. Maryanovich M, Oberkovitz G, Niv H, Vorobiyov L, Zaltsman Y, Brenner O, et al. The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nat Cell Biol 2012; 14:535-41; PMID:22446738; http://dx.doi.org/10. 1038/ncb2468
79. Yoshida T, Hazan I, Zhang J, Ng SY, Naito T, Snippert HJ, et al. The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. Genes Dev 2008; 22:1174-89; PMID:18451107; http://dx.doi.org/10.1101/gad.1642808
80. Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, et al. The Paf oncogene is essential for hematopoietic stem cell function and development. J Exp Med 2011; 208:1757-65; PMID:21844206; http://dx.doi.org/10.1084/jem. 20102170
81. Xiao N, Jani K, Morgan K, Okabe R, Cullen DE, Jesneck JL, et al. Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress. Blood 2012; 119:4898-907; PMID:22490678; http://dx.doi.org/10.1182/blood-2012-01-403089
82. Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest 2008; 118:2832-44; PMID:18618018
83. Suzuki N, Yamazaki S, Ema H, Yamaguchi T, Nakauchi H, Takaki S. Homeostasis of hematopoietic stem cells regulated by the myeloproliferative disease associated-gene product Lnk/Sh2b3 via Bcl-xL. Exp Hematol 2012; 40:166-74, e3; PMID:22101255; http://dx.doi.org/10.1016/j.exphem.2011.11.003